TechFlex is dedicated to assisting startups in the Series A and Seed money stages to achieve their objectives through a structured and supportive framework. Our approach focuses on providing tailored solutions that address the unique challenges faced by early-stage companies.
TechFlex is the catalyst for success in the medical device industry, offering comprehensive support to growing companies. With expertise spanning from initial concept to market entry, TechFlex provides tailored solutions, cutting-edge technologies, and regulatory guidance.
Medical technology company Stryker has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Incompass Total Ankle System. The implant is intended for patients suffering from severely damaged ankle joints due to rheumatoid, post-traumatic, or degenerative arthritis.
Read the full article at: www.3printr.com
